Quick Answer
IMMUNIC, INC. reported Operating Income Loss of -$103.23 million for the year ending 2025.
- IMMUNIC, INC. showed a decrease of -5.3% in Operating Income Loss from 2024 to 2025.
- This data is from IMMUNIC, INC.'s annual report (Form 10-K), filed with the SEC on February 26, 2026.
- XBRL data for this metric is available from 2012 to 2025 (14 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q1 2013: -$4.93 million | Q2 2013: -$7.06 million | Q3 2013: -$9.17 million | Q1 2014: -$11.88 million | Q2 2014: -$11.64 million | Q3 2014: -$12.81 million | Q1 2015: -$14.82 million | Q2 2015: -$15.08 million | Q3 2015: -$12.34 million | Q1 2016: -$9.66 million | Q2 2016: -$9.55 million | Q3 2016: -$10.24 million | Q1 2017: -$12.69 million | Q2 2017: -$12.55 million | Q3 2017: -$12.64 million | Q1 2018: -$14.49 million | Q2 2018: -$2.67 million | Q3 2018: -$1.81 million | Q1 2019: -$4.66 million | Q2 2019: -$15.01 million | Q3 2019: -$9.18 million | Q1 2020: -$9.01 million | Q2 2020: -$12.22 million | Q3 2020: -$13.55 million | Q1 2021: -$32.39 million | Q2 2021: -$19.17 million | Q3 2021: -$18.39 million | Q1 2022: -$21.44 million | Q2 2022: -$20.61 million | Q3 2022: -$20.12 million | Q1 2023: -$27.25 million | Q2 2023: -$25.02 million | Q3 2023: -$23.57 million | Q1 2024: -$23.88 million | Q2 2024: -$22.81 million | Q3 2024: -$25.73 million | Q1 2025: -$26.83 million | Q2 2025: -$27.08 million | Q3 2025: -$25.99 million.
- Over the full 14 years of available data (2012 to 2025), IMMUNIC, INC.'s Operating Income Loss has declined by 977.5%.
- Historical annual values: Fiscal year 2025: -$103.23 million | Fiscal year 2024: -$98.05 million | Fiscal year 2023: -$99.22 million | Fiscal year 2022: -$119.49 million | Fiscal year 2021: -$91.67 million | Fiscal year 2020: -$48.97 million | Fiscal year 2019: -$37.03 million | Fiscal year 2018: -$12.00 million | Fiscal year 2017: -$52.66 million | Fiscal year 2016: -$41.27 million | Fiscal year 2015: -$52.12 million | Fiscal year 2014: -$50.34 million | Fiscal year 2013: -$31.40 million | Fiscal year 2012: -$9.58 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: